CELTY
CELTY
Celltrion
No verified price for this holding
We could not match CELTY to a listing with a confirmed company name, so no price is shown. Everything below — sector, fund exposure and weights — comes from the published holdings of the funds themselves.
Which ETFs hold CELTY?
Celltrion appears in 1 of the funds we track, with its heaviest allocation at 2.20% in EWY.
| ETF | Fund | Weight | Category | Market |
|---|---|---|---|---|
| EWY | iShares MSCI South Korea ETF | 2.20% | Country/Region | 🇰🇷 South Korea |
Other healthcare holdings
AZN
AstraZeneca · 9 ETFs
LLY
Eli Lilly · 8 ETFs
JNJ
Johnson & Johnson · 8 ETFs
UNH
UnitedHealth Group · 7 ETFs
ABBV
AbbVie · 6 ETFs
RHHBY
Roche Holdings · 6 ETFs
NVO
Novo Nordisk · 5 ETFs
CSL
CSL Limited · 5 ETFs
Community
CELTY discussion
Questions on fair value, cost, dividends and risk — answered with the fund data on this page.
Which ETFs hold CELTY, and how much exposure do you already have?
CELTY stock forecast 2026: what the data does and does not tell you
Ask a question about CELTY
Questions are reviewed before publishing. Please do not ask for personal investment advice — we cannot provide it.